FUSE
MCID: PLY150
MIFTS: 29

Polykaryocytosis Inducer (FUSE)

Aliases & Classifications for Polykaryocytosis Inducer

MalaCards integrated aliases for Polykaryocytosis Inducer:

Name: Polykaryocytosis Inducer 57
Fuse 57

External Ids:

OMIM® 57 174750

Summaries for Polykaryocytosis Inducer

MalaCards based summary : Polykaryocytosis Inducer, also known as fuse, is related to spondyloarthropathy 1 and tarsal-carpal coalition syndrome. An important gene associated with Polykaryocytosis Inducer is FUSE (Polykaryocytosis Promoter). The drugs Ranibizumab and Fentanyl have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and skeletal muscle.

More information from OMIM: 174750

Related Diseases for Polykaryocytosis Inducer

Diseases related to Polykaryocytosis Inducer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 98)
# Related Disease Score Top Affiliating Genes
1 spondyloarthropathy 1 11.1
2 tarsal-carpal coalition syndrome 11.0
3 ring chromosome 20 11.0
4 ankyloblepharon-ectodermal defects-cleft lip/palate 10.9
5 aortic valve disease 1 10.9
6 wildervanck syndrome 10.9
7 bifid nose with or without anorectal and renal anomalies 10.9
8 ring chromosome 14 syndrome 10.9
9 bladder exstrophy-epispadias-cloacal exstrophy complex 10.9
10 craniosynostosis 10.9
11 horseshoe kidney 10.9
12 iniencephaly 10.9
13 ring chromosome 13 10.9
14 ring chromosome 15 10.9
15 spondylolisthesis 10.3
16 adenoma 10.2
17 sudden infant death syndrome 10.1
18 back pain 10.1
19 immune deficiency disease 10.0
20 rett syndrome 10.0
21 hepatitis c virus 10.0
22 scoliosis 10.0
23 cholera 10.0
24 influenza 10.0
25 stomatitis 10.0
26 hypoxia 10.0
27 colorectal cancer 9.9
28 optic atrophy 1 9.9
29 scoliosis, isolated 1 9.9
30 lung cancer 9.9
31 human immunodeficiency virus type 1 9.9
32 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.9
33 colorectal adenoma 9.9
34 idiopathic scoliosis 9.9
35 hepatitis c 9.9
36 liver cirrhosis 9.9
37 spinal stenosis 9.9
38 chronic pain 9.9
39 achondroplasia 9.8
40 bladder cancer 9.8
41 fibrosis of extraocular muscles, congenital, 1 9.8
42 gray platelet syndrome 9.8
43 hair whorl 9.8
44 ovarian cancer 9.8
45 pick disease of brain 9.8
46 prostate cancer 9.8
47 schizophrenia 9.8
48 small cell cancer of the lung 9.8
49 storage pool platelet disease 9.8
50 bloom syndrome 9.8

Graphical network of the top 20 diseases related to Polykaryocytosis Inducer:



Diseases related to Polykaryocytosis Inducer

Symptoms & Phenotypes for Polykaryocytosis Inducer

Clinical features from OMIM®:

174750 (Updated 20-May-2021)

Drugs & Therapeutics for Polykaryocytosis Inducer

Drugs for Polykaryocytosis Inducer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 83)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ranibizumab Approved Phase 4 347396-82-1 459903
2
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
3
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
4
afatinib Approved Phase 4 850140-72-6, 439081-18-2 10184653
5 Psychotropic Drugs Phase 4
6 Neurotransmitter Agents Phase 4
7 Hypnotics and Sedatives Phase 4
8 Narcotics Phase 4
9 Anesthetics Phase 4
10 Anesthetics, General Phase 4
11 Anesthetics, Intravenous Phase 4
12 Anti-Anxiety Agents Phase 4
13 GABA Modulators Phase 4
14 Analgesics, Opioid Phase 4
15 Cola Phase 4
16 Immunoglobulins, Intravenous Phase 4
17 Protein Kinase Inhibitors Phase 4
18 Pharmaceutical Solutions Phase 2, Phase 3
19 polysaccharide-K Phase 2, Phase 3
20
Heparin Approved, Investigational Phase 1, Phase 2 9005-49-6 772 9812414
21
Aluminum hydroxide Approved, Investigational Phase 2 21645-51-2
22
Bevacizumab Approved, Investigational Phase 2 216974-75-3
23 Anticoagulants Phase 1, Phase 2
24 Serine Proteinase Inhibitors Phase 1, Phase 2
25 Antithrombins Phase 1, Phase 2
26 Antithrombin III Phase 1, Phase 2
27 Liver Extracts Phase 1, Phase 2
28 Tissue Plasminogen Activator Phase 1, Phase 2
29 Heparin Cofactor II Phase 1, Phase 2
30 HIV Protease Inhibitors Phase 1, Phase 2
31 calcium heparin Phase 1, Phase 2
32
protease inhibitors Phase 1, Phase 2
33 N-(2-aminoethyl)-5-isoquinolinesulfonamide Phase 2
34 Adjuvants, Immunologic Phase 2
35 Interleukin-4 Phase 2
36 Hemagglutinins Phase 2
37 Chrysanthemum Phase 1, Phase 2
38 Mitogens Phase 2
39 Endothelial Growth Factors Phase 2
40 Muromonab-CD3 Phase 2
41
Serine Investigational, Nutraceutical Phase 1, Phase 2 56-45-1 5951
42
Kanamycin Approved, Investigational, Vet_approved Phase 1 59-01-8, 8063-07-8 6032
43
Palivizumab Approved, Investigational Phase 1 188039-54-5
44
Ibalizumab Approved, Investigational Phase 1 680188-33-4
45
nivolumab Approved Phase 1 946414-94-4
46
Cysteine Approved, Nutraceutical Phase 1 52-90-4 5862
47 Interleukin-2 Phase 1
48
rituximab Approved 174722-31-7 10201696
49
Epinephrine Approved, Vet_approved 51-43-4 5816
50
Racepinephrine Approved 329-65-7 838

Interventional clinical trials:

(show top 50) (show all 95)
# Name Status NCT ID Phase Drugs
1 Clinical Trial to Evaluate the Efficacy and Safety of SurgiFill™ on Spinal Fusion -Comparison Between Autograft Mixed With SurgiFill™ and Autograft in Spinal Fusion- Unknown status NCT02466048 Phase 4
2 Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study Unknown status NCT02651168 Phase 4
3 Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept Unknown status NCT03468296 Phase 4 Intravitreal Aflibercept Injection 2mg
4 Fentanyl Use for Sedation in Esophagogastroduodenoscopy (FUSE): a Phase 4, Randomized, Double-blind, Placebo-controlled Trial of Fentanyl Added to Midazolam Compared to Midazolam Alone for Sedation in Routine Upper Endoscopy Completed NCT01514695 Phase 4 Midazolam;Fentanyl
5 Single Center, Prospective, Open Label Post Marketing Study of EndoChoice's Fuse® Endoscopic System Performance In Routine Practice Completed NCT02439502 Phase 4
6 RCT Comparing i-FACTOR and Allograft in Spinal Fusion Surgery Completed NCT02895555 Phase 4
7 A Phase IV Randomised Clinical Trial of Laser Therapy for Peripheral Retinal Ischaemia Combined With Intravitreal Aflibercept (Eylea®) Versus Intravitreal Aflibercept Monotherapy for Diabetic Macular Oedema Active, not recruiting NCT02432547 Phase 4 Aflibercept
8 An Open-Labeled, Single-Arm Clinical Study to Evaluate the Efficacy of Afatinib in Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer With NRG1-Fusion Not yet recruiting NCT04814056 Phase 4 Afatinib Dimaleate
9 Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study Completed NCT01813773 Phase 2, Phase 3 Intravitreal Aflibercept Injection (IAI)
10 Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma (DOBL) - A Randomised Phase III Non- Inferiority Trial. Recruiting NCT02964858 Phase 3
11 A Phase 1-3 Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION363 in Amyotrophic Lateral Sclerosis Patients With Fused in Sarcoma Mutations (FUS-ALS) Not yet recruiting NCT04768972 Phase 3 ION363;Placebo
12 A Randomized Phase II Study of Immunization Against Melanoma Comparing Autologous Dendritic Cells Pulsed With gp100 Peptide to Autologous Dendritic Cells Fused With Autologous Tumor Cells Unknown status NCT00085397 Phase 2
13 A Phase 1 / 2 Clinical Trial to Assess the Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis Unknown status NCT02342691 Phase 1, Phase 2 BLXA4;Placebo oral rinse
14 A Phase I/II Study to Assess the Safety, Immunogenicity and Protective Efficacy of Novel Malaria Vaccine Candidates ChAdOx1 LS2 and MVA LS2 in Healthy UK Adults Completed NCT03203421 Phase 1, Phase 2
15 A Randomized, Active-controlled, Multiple-dose, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of the Long-acting Antibody-fused Recombinant Human Growth Hormone (GX-H9) in Adult Growth Hormone Deficiency (AGHD) Completed NCT02946606 Phase 2 GX-H9;Genotropin
16 A Phase 2, Randomized, Open-label, Active Controlled, Dose Finding Study of Long-acting Hybrid Fc Fused Recombinant Human Growth Hormone (GX-H9) in Paeditaric Patients With Growth Hormone Deficiency Completed NCT03309891 Phase 2 GX-H9;Genotropin
17 An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma Completed NCT02858895 Phase 2 MDNA55
18 A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases Completed NCT01227954 Phase 2
19 A Phase II, Open-label, Escalating Dose-ranging Study to Evaluate the Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults ≥65 Years of Age Completed NCT00966238 Phase 2
20 A Phase I/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Using the Intra-patient Escalation Dosing Regimen in Patients With Advanced Uveal Melanoma Active, not recruiting NCT02570308 Phase 1, Phase 2 IMCgp100
21 A Phase 2a Multicenter Randomized Controlled Trial Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion) Compared to Standard of Care in the Repair of Mixed Motor-sensory Acute Peripheral Nerve Injuries (PNI) for Rapid and Immediate Improvement in Outcome Not yet recruiting NCT04789044 Phase 2 NTX-001
22 Safety, Immunogenicity, and Efficacy of R21/Matrix-M and ChAd63/MVA-ME-TRAP in the Context of Controlled Human Malaria Infection: A Phase IIb Trial in Kenyan Adults Not yet recruiting NCT03947190 Phase 2
23 Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa Not yet recruiting NCT04658914 Phase 2
24 A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer Who Have Failed First-Line Therapy Terminated NCT02045030 Phase 2 aflibercept + FOLFIRI
25 An Open-label, Multi-center, Rollover Study in Patients With Advanced Melanoma After Completing an IMCgp100 Clinical Study Terminated NCT02889861 Phase 2 IMCgp100
26 A Phase I/II Trial of CDX-1401 (a Vaccine Consisting of a Human Monoclonal Antibody Specific for DEC-205, Fused to Full-length Tumor Antigen NY-ESO-1) in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients Withdrawn NCT02661100 Phase 1, Phase 2 Pembrolizumab
27 Human OK99 Allogeneic Stem Cell Transplantation for Patients With Severe Parkinson's Disease Unknown status NCT02780895 Phase 1 Human Stem Cells
28 BION Stimulation to Improve Swallowing Function After Radical Head-neck Surgery and Follow-up Chemoradiation Therapy Completed NCT00628485 Phase 1
29 Restoration of Daily-life Hand Function Using a Brain/Neural-Computer Interaction (BNCI) System in Paralysis After Cervical Spinal Cord Injury Completed NCT02336321 Phase 1
30 RV 151: A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults, WRAIR #984, HSRRB Log # A-11905. Completed NCT00412477 Phase 1
31 A Phase 1 Double Blinded, Randomized, Placebo-controlled Dose Escalation Study to Examine the Safety, Reactogenicity, Tolerability and Immunogenicity of the P2-VP8 Subunit Rotavirus Vaccine in Healthy Adult Volunteers Completed NCT01764256 Phase 1
32 Phase I Study of Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers Completed NCT02159716 Phase 1
33 Randomized, Placebo-controlled, Double-blind, Phase 1, Dose-escalating Study to Evaluate the Safety and Immunogenicity of a Synthetic Virus Like Particle (SVLP) Vaccine Against Respiratory Syncytial Virus (RSV) Recruiting NCT04519073 Phase 1
34 A Phase I, Multicenter Study of CD4- Directed Chimeric Antigen Receptor Engineered T-cells (CD4CAR) in Patients With Relapsed or Refractory CD4+ Hematological Malignancies Recruiting NCT03829540 Phase 1
35 VRC 323: A Phase I Open-Label Clinical Trial to Evaluate the Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults Recruiting NCT04579250 Phase 1
36 Phase Ib Study of Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases Active, not recruiting NCT03807765 Phase 1 Nivolumab
37 VRC 321: A Phase I Open-Label Clinical Trial to Evaluate Dose, Safety, Tolerability, and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine, VRCFLUNPF099-00-VP, in Healthy Adults Active, not recruiting NCT03814720 Phase 1
38 Treatment of Relapsed or Refractory Neuroblastoma With Ex-Vivo Expanded and Activated Haploidentical NK Cells and Hu14.18-IL2 Suspended NCT03209869 Phase 1
39 An Initial Feasibility Study to Integrate High-precision, Image Guided, Radiotherapy(MRI Based Brachytherapy and CT/MRI Fused Dynamic IMRT Planning) in the Treatment Planning of 10 Patients With Locally Advanced Carcinoma of the Cervix Withdrawn NCT01514955 Phase 1
40 BION Implantable Microstimulator System Withdrawn NCT00689286 Phase 1
41 A Study to Evaluate the Safety and Effectiveness of the TOPS™ SP System Unknown status NCT03247166
42 Web-based International Multi-Center Clinical Study for Parkinson's Disease; the Evaluation of Clinical Outcome Based on the Electrode Position Estimated From the Fused Images of Preoperative MRI and Postoperative CT After Bilateral STN DBS Unknown status NCT01696812
43 Assessment of Peri-Implant Tissues Surrounding PEEK and Porcelain Fused to Metal Superstructures in Posterior Region (Randomized Controlled Clinical Trial) Unknown status NCT03578913
44 The Influence of Porcelain Fused to Metal ( PFM) and Zirconia Crowns on Periodontal Health Unknown status NCT02461823
45 A Clinical Evaluation of Hand-veneered, Porcelain-fused NobelProcera(TM) Crown Shaded Zirconia and NobelProcera(TM) Full Contour Crown IPS e.Max CAD on Molars Unknown status NCT01835821
46 Evaluation of the Soft Tissue Stability Around Single Crowns Supported by Tissue Level Implants Placed in Non-augmented Healed Sites in the Anterior Maxilla: a Retrospective Study Unknown status NCT02061930
47 An Early Access Programme for Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia Approved for marketing NCT03501615 Moxetumomab Pasudotox
48 Post-bariatric Abdominoplasty: Skin Sensation Evaluation. Completed NCT00831610
49 Randomized Multi-Center Post Market Clinical Study to Evaluate the Safety and Performance of NextraTM for Use in Foot Surgery to Fuse the Proximal-interphalangeal- Joints Completed NCT01604070
50 Exploratory Study of Upper and Lower Endoscopic Fuse System Completed NCT02651857

Search NIH Clinical Center for Polykaryocytosis Inducer

Genetic Tests for Polykaryocytosis Inducer

Anatomical Context for Polykaryocytosis Inducer

MalaCards organs/tissues related to Polykaryocytosis Inducer:

40
Brain, Bone, Skeletal Muscle, Prostate, Liver, Bone Marrow, Heart

Publications for Polykaryocytosis Inducer

Articles related to Polykaryocytosis Inducer:

(show top 50) (show all 9994)
# Title Authors PMID Year
1
Gene assignment of a polykaryocytosis promoter (FUSE) to chromosome 10 in man. 57 61
752487 1978
2
Bilateral attention decoder: A lightweight decoder for real-time semantic segmentation. 61
33647536 2021
3
Is there significant regeneration of the hamstring tendons after harvest for ACL reconstruction? A systematic review of literature. 61
33680834 2021
4
Automated interpretation of congenital heart disease from multi-view echocardiograms. 61
33418465 2021
5
COVID-19 classification by CCSHNet with deep fusion using transfer learning and discriminant correlation analysis. 61
33519321 2021
6
Sacral co-ossification in dinosaurs: The oldest record of fused sacral vertebrae in Dinosauria and the diversity of sacral co-ossification patterns in the group. 61
33164207 2021
7
The immunophilin Zonda controls regulated exocytosis in endocrine and exocrine tissues. 61
33336828 2021
8
A Privacy-Preserving Cross-Domain Healthcare Wearables Recommendation Algorithm Based on Domain-Dependent and Domain-Independent Feature Fusion. 61
33793406 2021
9
Hydrophobe Containing Polypeptoids Complex with Lipids and Induce Fusogenesis of Lipid Vesicles. 61
33730500 2021
10
DNA-driven condensation assembles the meiotic DNA break machinery. 61
33731927 2021
11
Reciprocal connectivity of the periaqueductal gray with the ponto-medullary respiratory network in rat. 61
33515533 2021
12
Graph convolution network with similarity awareness and adaptive calibration for disease-induced deterioration prediction. 61
33388456 2021
13
An SNX10-dependent mechanism down-regulates fusion between mature osteoclasts. 61
33795396 2021
14
The Future Role of Machine Learning in Clinical Transplantation. 61
32826798 2021
15
On Being a Monkey's Uncle: Germline Chimerism in the Callitrichinae and the Evolution of Sibling Rivalry. 61
33755537 2021
16
Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion. 61
33674318 2021
17
Complementation in trans of Porphyromonas gingivalis lipopolysaccharide biosynthetic mutants demonstrates lipopolysaccharide exchange. 61
33685973 2021
18
Effects of bicornuate uterus on pregnancy and obstetric outcomes of in vitro fertilization / intracytoplasmic sperm injection. 61
33421810 2021
19
Mapping of the excitatory, inhibitory, and modulatory afferent projections to the anatomically defined active expiratory oscillator in adult male rats. 61
32656849 2021
20
Mobile late endosomes modulate peripheral endoplasmic reticulum network architecture. 61
33554435 2021
21
The shape of pleomorphic virions determines resistance to cell-entry pressure. 61
33737748 2021
22
FLANNEL (Focal Loss bAsed Neural Network EnsembLe) for COVID-19 detection. 61
33125051 2021
23
A novel method for identifying hotspots and forecasting air quality through an adaptive utilization of spatio-temporal information of multiple factors. 61
33246725 2021
24
MSDU-Net: A Multi-Scale Dilated U-Net for Blur Detection. 61
33800173 2021
25
Recurrent feature fusion learning for multi-modality pet-ct tumor segmentation. 61
33744750 2021
26
Fusing of Preoperative Magnetic Resonance and Intraoperative O-arm Images in Deep Brain Stimulation Enhance Intuitive Surgical Planning and Increase Accuracy of Lead Placement. 61
33790132 2021
27
A Digital Improvement-Trimming a Digital Temperature Sensor with EEPROM Reprogrammable Fuses. 61
33801214 2021
28
Computer-aided diagnosis of ground glass pulmonary nodule by fusing deep learning and radiomics features. 61
33596552 2021
29
Netrins: Evolutionarily Conserved Regulators of Epithelial Fusion and Closure in Development and Wound Healing. 61
33691313 2021
30
Multimodal fusion of EEG-fNIRS: a mutual information-based hybrid classification framework. 61
33796378 2021
31
Conventional Machine Learning versus Deep Learning for Magnification Dependent Histopathological Breast Cancer Image Classification: A Comparative Study with Visual Explanation. 61
33809611 2021
32
Gastrointestinal dysfunction in neuroinflammatory diseases: Multiple sclerosis, neuromyelitis optica, acute autonomic ganglionopathy and related conditions. 61
33740560 2021
33
Disentangle, Align and Fuse for Multimodal and Semi-Supervised Image Segmentation. 61
33156786 2021
34
IRC-Fuse: improved and robust prediction of redox-sensitive cysteine by fusing of multiple feature representations. 61
33392948 2021
35
Covid-19 classification by FGCNet with deep feature fusion from graph convolutional network and convolutional neural network. 61
33052196 2021
36
Nickel-Sulfonate Mode of Substrate Binding for Forward and Reverse Reactions of Methyl-SCoM Reductase Suggest a Radical Mechanism Involving Long-Range Electron Transfer. 61
33761259 2021
37
Role of Exosomes in Prostate Cancer Metastasis. 61
33805398 2021
38
Dual-task ultrasound spine transverse vertebrae segmentation network with contour regularization. 61
33752079 2021
39
Paving the Way for Fertilization: The Role of the Transmitting Tract. 61
33807566 2021
40
Dynamic Dissection of the Endocytosis of Porcine Epidemic Diarrhea Coronavirus Cooperatively Mediated by Clathrin and Caveolae as Visualized by Single-Virus Tracking. 61
33785615 2021
41
Importance-aware personalized learning for early risk prediction using static and dynamic health data. 61
33496786 2021
42
Conducting polymers as anion-responsive chemical fuses. 61
33734262 2021
43
Evaluation of lung involvement in COVID-19 pneumonia based on ultrasound images. 61
33743707 2021
44
Automatic Modulation Classification Based on Deep Feature Fusion for High Noise Level and Large Dynamic Input. 61
33803042 2021
45
C-UNet: Complement UNet for Remote Sensing Road Extraction. 61
33808588 2021
46
Disease-associated metabolic alterations that impact satellite cells and muscle regeneration: perspectives and therapeutic outlook. 61
33766031 2021
47
Accurate Correlation Modeling between Wind Speed and Bridge Girder Displacement Based on a Multi-Rate Fusion Method. 61
33799625 2021
48
Learning Generalisable Omni-Scale Representations for Person Re-Identification. 61
33769931 2021
49
Autophagy and the endolysosomal system in presynaptic function. 61
33340068 2021
50
A Scaffold- and Serum-Free Method to Mimic Human Stable Cartilage Validated by Secretome. 61
30734654 2021

Variations for Polykaryocytosis Inducer

Expression for Polykaryocytosis Inducer

Search GEO for disease gene expression data for Polykaryocytosis Inducer.

Pathways for Polykaryocytosis Inducer

GO Terms for Polykaryocytosis Inducer

Sources for Polykaryocytosis Inducer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 20-May-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....